DABUR - Dabur India
📢 Recent Corporate Announcements
Dabur India has received directions from the NCLT to convene meetings of its equity shareholders and unsecured creditors regarding the merger with Sesa Care Private Limited. Sesa Care is a prominent player in the Ayurvedic hair oil segment with a paid-up capital of ₹966.50 crore. The merger, with an appointed date of April 1, 2026, aims to consolidate Dabur's market leadership by integrating Sesa's premium brand portfolio. This strategic move is expected to drive cost optimizations and distribution synergies across domestic and international markets.
- NCLT order dated March 12, 2026, directs Dabur to hold meetings for shareholders and unsecured creditors.
- Sesa Care holds the 3rd position in the Ayurvedic hair oil category, filling a strategic gap in Dabur's portfolio.
- The paid-up share capital of Sesa Care is ₹966.50 crore compared to Dabur's ₹177.37 crore.
- The scheme sets April 1, 2026, as the appointed date for the amalgamation.
- Synergies are expected through combined financial, technical, and distribution resources.
ICRA Limited has reaffirmed the highest credit ratings for Dabur India Limited's debt instruments and bank facilities. The company's Rs 250 crore Non-Convertible Debentures (NCD) programme maintained its [ICRA]AAA (Stable) rating. Additionally, bank facilities totaling Rs 1,000 crore were reaffirmed at [ICRA]AAA (Stable) and [ICRA]A1+. This reaffirmation underscores Dabur's strong financial profile and high degree of safety regarding timely servicing of financial obligations.
- ICRA reaffirmed [ICRA]AAA (Stable) rating for Rs 250 crore Non-Convertible Debentures.
- Total bank facilities of Rs 1,000 crore reaffirmed at [ICRA]AAA (Stable) and [ICRA]A1+.
- Bank limits include fund-based facilities from HDFC Bank (Rs 145 cr) and Standard Chartered (Rs 200 cr).
- Short-term interchangeable bank limits of Rs 175 crore reaffirmed at [ICRA]A1+.
Dabur India has announced its first investment through its 'Dabur Ventures' platform, acquiring a minority stake in luxury skincare D2C brand RAS Beauty for approximately Rs 60 Crore. RAS Beauty is a high-growth, digital-first company reporting a 3-year CAGR of 75% and an Annual Recurring Revenue (ARR) of nearly Rs 100 Crore. This strategic move marks Dabur's entry into the premium beauty segment, leveraging the target's high gross margins and 'Farm-to-Face' positioning. The investment will be used to scale RAS Beauty's omnichannel presence and R&D capabilities.
- Investment of Rs 60 Crore for a minority stake in luxury skincare brand RAS Beauty
- RAS Beauty demonstrates strong growth with a 3-year CAGR of 75% and ARR of ~Rs 100 Crore
- First deployment from the Rs 500 Crore Dabur Ventures fund launched in October 2025
- Target company operates in the high-margin premium D2C segment with in-house R&D and manufacturing
Dabur India Limited has successfully appealed against a tax demand totaling ₹3,12,74,277 issued by the State Tax authorities in Alwar, Rajasthan. The dispute, which involved product classification issues for the financial years 2017-18, 2018-19, and 2019-20, has been resolved in the company's favor. The 1st Appellate Authority has set aside the entire demand, including tax, interest, and penalties. The company has confirmed that this resolution will have no impact on its ongoing operations or financial activities.
- Appellate Authority set aside a total tax demand of ₹3,12,74,277.
- The demand included ₹97,28,014 in tax, ₹1,18,18,249 in interest, and ₹97,28,014 in penalty.
- Dispute related to product classification for FY 2017-18, 2018-19, and 2019-20.
- The favorable order was received by the company on February 26, 2026.
- Company confirms zero impact on business operations following this legal victory.
Dabur India Limited has filed a report regarding the special window for re-lodging physical share transfer requests as per SEBI guidelines. During the period from January 1 to January 6, 2026, the company's registrar, KFin Technologies, received one request covering seven folios. This single request was processed and approved within an average timeframe of three days. This disclosure is a routine regulatory requirement and does not impact the company's financial performance.
- Compliance with SEBI Circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 regarding physical shares
- One transfer request received covering a total of 7 folios between Jan 1-6, 2026
- 100% approval rate with one request processed and approved during the period
- Average processing time for the transfer request recorded at 3 days
Dabur India has announced a strategic leadership restructuring to strengthen its domestic and international operations. Mr. Mohit Malhotra has been redesignated as the Global CEO, while Mr. Herjit S. Bhalla, an FMCG veteran with 25 years of experience, has been appointed as the CEO for the India Business effective April 15, 2026. Mr. Bhalla joins from The Hershey Company and has previously held leadership roles at Unilever and Metro Cash & Carry. This move signals Dabur's intent to scale its global footprint while bringing in specialized leadership for its core Indian market.
- Mohit Malhotra redesignated as Whole Time Director & Global CEO effective February 17, 2026.
- Herjit S. Bhalla appointed as CEO - India Business, effective April 15, 2026.
- Mr. Bhalla brings over 25 years of experience from major FMCG players including Unilever and The Hershey Company.
- The India CEO will report directly to the Global CEO, ensuring strategic alignment across geographies.
- Mr. Bhalla's most recent role was VP Canada & Global Customers at The Hershey Company.
Dabur India Limited has announced its participation in two major group investor conferences scheduled for February 2026. The company will attend the Nuvama India Investor Conference on February 9 and Axis Capital's Flagship India Conference on February 10. Both events will be held physically in Mumbai starting at 10:00 AM IST. The company has clarified that no unpublished price sensitive information will be shared during these interactions.
- Scheduled to attend Nuvama India Investor Conference on February 9, 2026, at 10:00 AM
- Scheduled to attend Axis Capital's Flagship India Conference on February 10, 2026, at 10:00 AM
- Both conferences will be held in physical mode at venues in Mumbai (Grand Hyatt and Trident BKC)
- Company officials will engage in group investor meetings to discuss business outlook
- Explicit statement that no Unpublished Price Sensitive Information (UPSI) will be disclosed
Dabur India Limited has announced its participation in two major investor conferences scheduled for February 2026 in Mumbai. On February 9, the company will attend the Nuvama India Investor Conference at Hotel Grand Hyatt, followed by Axis Capital's Flagship India Conference on February 10 at Hotel Trident, BKC. Both events are physical group meetings starting at 10:00 AM IST. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during these sessions.
- Scheduled to attend Nuvama India Investor Conference on February 9, 2026, at 10:00 AM.
- Scheduled to attend Axis Capital's Flagship India Conference on February 10, 2026, at 10:00 AM.
- Both conferences are physical group meetings held at major venues in Mumbai.
- Company confirms that no Unpublished Price Sensitive Information (UPSI) will be disclosed.
- Disclosure made under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.
Dabur India reported a 6.1% YoY revenue growth for Q3 FY26, supported by a 6% growth in domestic FMCG and 3% volume growth. The Home & Personal Care (HPC) segment was a standout performer with 10.6% growth, while the Hair Oil portfolio surged 19.1% due to price hikes and market share gains. Despite a one-time labor law provision, PAT grew by 10.1% (7.2% adjusted), benefiting from cost-saving measures and rural markets outperforming urban areas. Management remains optimistic about sequential demand recovery and the modernization of legacy brands.
- Consolidated revenue grew 6.1% YoY with domestic volume growth of 3%.
- Hair Oil portfolio grew 19.1% YoY, reaching an all-time high volume market share of 20%.
- Oral care segment saw 10% growth, with Meswak and Herbal brands growing 25% each.
- International business grew 11% in INR terms, led by 30% growth in Sub-Saharan Africa and UK/EU.
- Adjusted PAT grew 7.2% after accounting for a one-time labor law provision.
Dabur India Limited has released the audio recording of its Investors' Conference Call held on January 29, 2026. This call followed the declaration of the company's financial results for the third quarter and nine months ended December 31, 2025. The recording provides management's commentary on the company's performance and strategic outlook. Such disclosures are standard procedure to ensure transparency for all stakeholders following quarterly earnings announcements.
- Audio recording of the Q3 FY 2025-26 conference call is now publicly accessible.
- The call was conducted on January 29, 2026, post-financial result declaration.
- Filing is in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
- Covers performance insights for the nine-month period ending December 31, 2025.
Dabur India reported a steady Q3 FY26 with consolidated revenue growing 6.1% YoY to ₹3,558.6 crore, supported by a 3% volume growth in the domestic FMCG business. Profit After Tax (before exceptional items) grew by 10.1% to ₹575 crore, showcasing margin expansion despite input cost pressures. The company faced one-time headwinds from the New Labour Code implementation and GST-related inventory liquidation in October. International business remained strong with 11.1% growth, while the Healthcare segment led domestic growth at 10.6%.
- Consolidated Revenue rose 6.1% YoY to ₹3,558.6 Cr with India FMCG volume growth at 3%.
- PAT (before exceptional items) increased 10.1% YoY to ₹575 Cr; Operating Profit grew 7.7% to ₹734.1 Cr.
- Healthcare segment grew 10.6% YoY, while Hair Care saw 19.1% growth in the Amla franchise.
- International business grew 11.1% in INR terms, led by strong performance in US (19.3%) and UK (22.6%).
- Significant market share gains recorded in Hair Oils (+193 bps) and Activ Juices (+650 bps).
Dabur India reported a steady Q3 FY26 performance with consolidated revenue rising 6.1% YoY to ₹3,559 crore and net profit increasing 10.1% to ₹575 crore. The company demonstrated resilience with rural demand outperforming urban markets for the eighth consecutive quarter by a margin of 330 basis points. Significant market share gains were achieved in the Hair Oils and Juices categories, while the international business grew by 11.1%. Operating profit also saw a healthy growth of 7.7% despite input cost pressures.
- Consolidated Revenue grew 6.1% YoY to ₹3,559 Crore, with India FMCG business up 6%.
- Net Profit surged 10.1% to ₹575 Crore, while Operating Profit grew 7.7% to ₹734 Crore.
- Hair Oils segment posted a 19.1% growth, reaching a record-high market share of approximately 20%.
- International business grew 11.1% in constant currency, led by 20.2% growth in Bangladesh and 19.3% in the US.
- Total distribution reach expanded to 8.5 million outlets, covering over 133,000 villages.
Dabur India Limited reported a steady performance for the quarter ended December 31, 2025, with consolidated revenue growing 6.1% YoY to ₹3,558.65 crore. Net profit for the period increased by 7.3% to ₹553.61 crore, despite an exceptional charge of ₹15.05 crore. The core Consumer Care business remains the primary growth driver, contributing ₹3,064.46 crore to the topline, while the Food business saw a marginal decline. Overall, the company maintained stable margins with EPS rising to ₹3.16 from ₹2.95 YoY.
- Consolidated Revenue from Operations grew 6.1% YoY to ₹3,558.65 crore.
- Net Profit increased 7.3% YoY to ₹553.61 crore from ₹515.82 crore.
- Consumer Care segment revenue rose to ₹3,064.46 crore, up from ₹2,850.34 crore in the previous year.
- Earnings Per Share (EPS) improved to ₹3.16 from ₹2.95 in the corresponding quarter.
- The company recognized an exceptional item of ₹15.05 crore during the quarter.
Dabur India Limited has announced its earnings conference call to discuss the financial results for the third quarter and nine months ended December 31, 2025. The call is scheduled for January 29, 2026, at 5:00 PM IST, following the official declaration of results. Investors can access the call via universal dial-in numbers or a one-way audio webcast on the company's website. This is a standard procedure for the company to provide management commentary on operational performance and future outlook.
- Conference call scheduled for January 29, 2026, at 5:00 PM IST
- Covers financial performance for Q3 and the nine-month period ending December 31, 2025
- Universal dial-in numbers provided: +91 22 6280 1110 and +91 22 7115 8011
- International toll-free numbers available for USA, UK, Singapore, and Hong Kong
Dabur India Limited has submitted its monthly report regarding the special window for re-lodging physical share transfer requests as mandated by SEBI. For the period ending December 31, 2025, the company's Registrar and Share Transfer Agent, KFin Technologies, reported zero requests received. Consequently, no requests were processed, approved, or rejected during this timeframe. This filing is a part of ongoing regulatory compliance and does not impact the company's operational or financial performance.
- Dabur reported zero (NIL) requests for re-lodgement of physical share transfers in December 2025
- The report was filed in compliance with SEBI Circular dated July 2, 2025
- KFin Technologies Limited confirmed no processing activity or pending requests for the month
- Average time taken for processing such requests was reported as Not Applicable (NA)
Financial Performance
Revenue Growth by Segment
Consolidated revenue grew 1.3% YoY to INR 12,563 Cr in FY25. Home & Personal Care (HP&C) constitutes ~35% of revenue; International business contributes 26.1% and grew 7.5% YoY in FY25. In FY24, HP&C grew 8% while Foods & Beverages (F&B) remained stable despite double-digit growth in the foods sub-segment due to weak beverage performance.
Geographic Revenue Split
Domestic India business accounts for ~74-75% of revenue. International business contributes ~25-26% of overall revenue, with high double-digit growth witnessed in the Middle East during FY24.
Profitability Margins
Gross margin stood at 47.6% in FY25. Operating margin was 18.6% in FY25, down from 19.5% in FY24 due to lower cost absorption and higher operational spending. 9M FY25 operating margin recovered to 19.4%. PAT margin was 13.9% in FY25 compared to 14.6% in FY24.
EBITDA Margin
Operating margin (OPBDIT/OI) was 19.4% for 9M FY25, remaining steady YoY. FY24 margin was 19.4% compared to 18.8% in FY23, an improvement of 60 basis points driven by moderating input cost inflation.
Capital Expenditure
Annual maintenance capex is projected at INR 300-500 Cr. A specific greenfield plant in Tamil Nadu is being set up at a cost of INR 400 Cr to be incurred over 5 years, funded entirely through internal accruals.
Credit Rating & Borrowing
CRISIL AAA/Stable and CRISIL A1+ ratings maintained. Interest coverage ratio was 20.51 times in FY25, down from 33.60 times in FY24. Total debt to OPBDIT stood at 0.6 times in FY24.
Operational Drivers
Raw Materials
Key raw materials include agricultural commodities and packaging materials; specific names not listed, but they faced 8% inflation in H1 FY25 which was offset by a 5% price increase and INR 60 Cr in saving initiatives.
Import Sources
Sourced globally and domestically to support 14 manufacturing units in India and 8 overseas units in UAE, Sri Lanka, South Africa, Nepal, Egypt, Bangladesh, Turkey, and Nigeria.
Capacity Expansion
Current manufacturing footprint includes 22 locations globally. Expansion includes a new multi-category plant in Tamil Nadu (INR 400 Cr investment) to enhance penetration in South India.
Raw Material Costs
Raw material prices declined in FY24 leading to margin expansion to 19.5%, but inflation returned in FY25. The company uses saving initiatives (INR 60 Cr in H1) to mitigate cost spikes.
Manufacturing Efficiency
Operating efficiency is maintained through a 'Power Brand' focus and a distribution network of 7.7 million retail outlets. Saving initiatives of INR 60 Cr targeted for the current fiscal.
Logistics & Distribution
Distribution network covers 7.7 million retail outlets as of March 2023. The company organizes its sales force by zones to ensure deep rural and urban penetration.
Strategic Growth
Expected Growth Rate
5-7%
Growth Strategy
Growth will be driven by the 'Power Brand' strategy (focusing on 9 key brands), expanding the distribution network, and a INR 500 Cr outlay for 'Dabur Ventures' to acquire digital-first brands. The merger with Sesa Care will expand the ayurvedic hair care portfolio, while the Badshah acquisition (51% for INR 587 Cr) drives entry into the branded spices market.
Products & Services
Chyawanprash, Honey, Honitus, Pudin Hara, Lal Tail, Real Juices, Amla Hair Oil, Red Toothpaste, Vatika Shampoo, Badshah Spices, and Sesa Ayurvedic Oil.
Brand Portfolio
Dabur, Vatika, Real, Hajmola, Pudin Hara, Honitus, Lal Tail, Dabur Red, Dabur Amla, Dabur Chyawanprash, Dabur Honey, Badshah, Sesa.
New Products/Services
Expansion into branded spices via Badshah Masala and premium ayurvedic hair oils via Sesa Care. Digital-first brands under Dabur Ventures are expected to contribute to future high-growth categories.
Market Expansion
Focus on South India via the new Tamil Nadu plant and increasing rural reach where demand is currently outperforming urban markets.
Market Share & Ranking
Maintains leading market positions in health supplements (Chyawanprash/Honey), digestives, and ayurvedic OTC categories.
Strategic Alliances
Joint Venture with Forum 1 Aviation (20% stake). Acquisition of 51% in Badshah Masala with a path to 100% in 5 years.
External Factors
Industry Trends
Shift toward herbal and natural products (growing at a faster rate than traditional FMCG). Dabur is positioned as a leader in this 'Ayurvedic' trend but faces increasing competition from MNCs launching 'natural' variants.
Competitive Landscape
Intense competition from organized players (MNCs like HUL, Nestle) and unorganized local players in the herbal segment.
Competitive Moat
Strong brand equity in Ayurveda (Dabur name) and a massive distribution moat of 7.7 million outlets. Sustainability is driven by the 'Power Brand' focus which ensures high marketing support for market-leading products.
Macro Economic Sensitivity
Highly sensitive to food inflation which subdues urban demand and GDP growth which influences rural consumption patterns.
Consumer Behavior
Increasing health consciousness is driving demand for immunity boosters (Chyawanprash) and natural personal care, though high inflation is causing temporary down-trading in urban areas.
Geopolitical Risks
Operations in Turkey, Egypt, and Nigeria expose the company to currency devaluation and political instability risks.
Regulatory & Governance
Industry Regulations
Subject to FSSAI standards for food and AYUSH regulations for ayurvedic products. Compliance with plastic waste management and workplace safety (zero fatalities reported).
Environmental Compliance
Maintains a board-level ESG committee; 50% of the board consists of independent directors.
Taxation Policy Impact
Effective September 22, 2025, 86% of Dabur's portfolio moved to the 5% GST category from 12% and 18%, which is expected to support volume growth.
Legal Contingencies
Pending GST demand of INR 320 Cr (challenged by the company). US litigation regarding hair relaxer products at Namaste Laboratories LLC (subsidiary); management claims the portfolio is <1% of revenue.
Risk Analysis
Key Uncertainties
Outcome of US hair relaxer litigation and the INR 320 Cr GST show-cause notice could impact cash flows. Potential for 10-15% impact on quarterly earnings if liabilities materialize.
Geographic Concentration Risk
Significant dependence on the North and West Indian markets, though expanding in South India via the Tamil Nadu plant.
Technology Obsolescence Risk
Risk of digital-first D2C brands disrupting traditional categories; mitigated by the INR 500 Cr Dabur Ventures fund.
Credit & Counterparty Risk
Superior liquidity with INR 6,604 Cr in cash and liquid investments as of Sept 2024 ensures low counterparty risk.